Q&A Your Questions Answered

Burden of Multiple Myeloma

Treatment resources

Clinical trials

Download the ClinTrial Refer App

Latest News

Paediatric oncology parents are pleased with quality of care despite pandemic

This article originally published on The Limbic Most parents of children undergoing active cancer treatment at the RCH Children’s Cancer...
Continue Reading

PVd triplet therapy now on PBS for MM patients after first relapse

Pomalidomide (Pomalyst) in combination with bortezomib and dexamethasone (PVd) will be reimbursed on the PBS from 1 October for patients...
Continue Reading

ATAGI specifies which patients with haematological malignancy should have COVID-19 booster vax

People with blood cancers who are immunocompromised are now advised to have a third primary dose of COVID-19 vaccine with...
Continue Reading

‘I am screwed if it comes back’: Experts concerned by Covid’s hidden impact on blood cancer treatments

This article was originally posted on Stuff Around 21,000 Kiwis are living with blood cancer. Symptoms can be difficult to...
Continue Reading

Myeloma Research Review – Issue 39

Welcome to issue 39 of Multiple Myeloma Research Review. This issue’s selection includes research reporting that switching elderly intermediate-fit patients...
Continue Reading

Newsletter: Winter 2021

Dear AllWe are now certainly in the grip of a cold winter with many parts of the country experiencing significant...
Continue Reading


Every quarter we’ll post news and information in our myeloma newsletter. If you would like to join the community of patients and caregivers receiving this subscribe below.


Q & A – Your Questions Answered

Each month we’ll select questions to answer about multiple myeloma.  Submit your question via email here.

Questions selected and answered will be available on our Q&A page here. 

An email address is needed for administration purposes only and will remain confidential. Questions will be answered in the context of multiple myeloma in New Zealand.